Description:
Astragaloside II is extracted from roots of Astragalus membranaceus (Fisch.) Bunge. It stimulates osteoblast differentiation resulting in bone formation. It exhibits a significant induction of proliferation, differentiation and mineralization in primary osteoblasts. It is a potent MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy.
- Molecular Weight:827.01
- Boiling Point:897.4±65.0 °C | Condition: Press: 760 Torr
- Melting Point:221-226°C
- Purity:>98%
Molecular Formula:
C43H70O15
InChI:
InChI=1S/C41H66O15/c1-19(43)52-32-28(46)23(45)17-51-35(32)53-20-7-10-40-18-41(40)12-11-37(4)33(39(6)9-8-27(56-39)36(2,3)50)22(44)15-38(37,5)26(41)14-24(21(40)13-20)54-34-31(49)30(48)29(47)25(16-42)55-34/h20-35,42,44-50H,7-18H2,1-6H3/t20-,21?,22-,23+,24-,2
Solubility:
10 mM in DMSO
Appearance:
Powder
Application:
Astragaloside II has cardioprotective effects as well as causing improvement in cognitive function. It is used in the prevention of cardio-cerebral vascular diseases. It may be used as a potential adjunctive agent for hepatic cancer chemotherapy.
Storage: -20°C Freezer
Synonyms:
(3b,6a,16b, 20R,24S)-3-[(2-O-Acetyl-b-D-xylopyranosyl)oxy]-20,24-Epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl b-D-glucopyranoside Astrasieversianin VIII Weitere Informationen finden Sie
hier